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ABSTRACT
Aging impacts multiple organ systems, and specifically causes the immune
system to lose its ability to efficiently fight off infections (23, 30, 53, 70). Regarding
immunity, aging research predominantly focuses on the adaptive immune system.
Experiments illustrate the involution of the thymus as the host ages, which consequently
lead to the decline of newly developed T cells. Additionally, thymic involution
negatively affects the overall function of T cells. B cells, which mediate the humoral arm
of the adaptive immune system, develop throughout life in the bone marrow where
microenvironmental ‘niches’ are important. The bone marrow does not exactly ‘atrophy’
with age; however, studies comparing young and old mice demonstrate an age-related
change in the bone marrow B cell subpopulations. Changes in the aged bone marrow
reflect an increase in mature B cells and plasma cells, possibly due to an increase in
available niches, since there is a decline in immature B cells which also reside in these
niches (22, 23, 41, 49-51, 53, 70, 76, 77, 80, 82). Despite increases in antibody
producing plasma cells, there is an age-related decline of high affinity antibodies,
dampening the overall humoral response in the aged host (30, 49, 53). The decline in
high affinity antibodies is common in the elderly, providing an avenue in expanding our
knowledge of the bone marrow, and its effects on the humoral immune system.
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Once humans and other species reach adolescence, the marrow of long bones (for
example, femurs) converts from red to yellow marrow (4, 17). Marrow conversion alters
the production of multiple blood lineages, including lymphocytes. However, bone
marrow from other sites do not undergo conversion, suggesting there are different
hematopoietic marrows (45). An example of a non-converting bone marrow is located in
the sternum. Structurally, the femur and sternum are different. The femur is cortical
bone; the sternum is membraneous bone. With notable differences in bone marrow
conversion and structure, the femur and sternum may exhibit different cellular
composition in their bone marrow microenvironments. For example, bone marrow from
femur versus sternum may contain different resident lymphocytes. The difference in
bone marrow structure and marrow composition led me to hypothesize that the femur and
sternum represent different bone marrow microenvironments in regard to plasma cell
frequency and ability to support plasma cell survival in vitro. In particular, I hypothesize
that there will be an increased frequency of plasma cells in the sternum, compared to the
femur, since the sternum remains a site of hematopoiesis for the duration of the host’s
life. The overall goal of Aim 1 and part of Aim 2 was to determine if femoral and
sternum bone marrow have different plasma cell composition and growth factor
production that may affect antibody production and secretion. The goal of the first aim
was to determine if bone marrow from different sites represent similar or different plasma
cell niches. To compare the femur and sternum, I assessed murine bone marrow because
xiv

plasma cells accumulate there with age (91). Although mice do not undergo the red to
yellow bone marrow conversion, I questioned whether the bone marrows from these two
sites are different in regard to plasma cell frequency and survival. In order to answer this
question, I first assessed plasma cell frequency by immunofluorescence for intracellular
immunoglobulin and subsequently assessed plasma cell survival by co-culturing with
bone marrow-derived stromal cells from either bone marrow source.
Plasma cells require various signals from the microenvironment for their
maintenance and survival in vivo. One particular signal is provided from the TNF family
ligand, APRIL (A Proliferation Inducing Ligand) (5, 7). TACI (Transmembrane
Activator and Calcium Modulator and Cyclophilin Ligand Interactor), a receptor for
APRIL, is found on all peripheral B cells (89). The TACI and APRIL interaction has
been shown to be important in maintaining plasma cell number and function in both the
spleen and bone marrow. For example, mice treated with neutralizing TACI-Ig
demonstrated a decrease in both the frequency of mature B cells and overall antibody
production (29, 68). However, current research is lacking on the expression of both
TACI and APRIL in aged mice. The overall goal of my second aim was to determine if
the expression of APRIL and its receptor TACI are altered in aged mice. Since there is an
accumulation of mature B cells and plasma cells in aged bone marrow, I predicted an
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increased expression of APRIL mRNA in the both bone marrow sites and TACI on
femoral bone marrow B cells of aged mice, compared to young.
This study sought to determine the effects that age and cellular origin have on the
bone marrow microenvironment. The conclusions drawn from this work will help
expand the known mechanisms required for an efficient humoral response in the host.
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CHAPTER I
LITERATURE REVIEW
Humoral Immunity and B Lymphocyte Maturation
We are constantly exposed to harmful agents, yet we remain relatively healthy.
Protection is governed in part by the humoral immune system. Humoral immunity is
mediated by plasma cells and their production of antigen-specific antibodies. These
proteins are secreted into the blood and lymphatics to target and eliminate foreign
antigens that could otherwise be detrimental to the host (1, 36, 78). Protection is longlasting, and antigen-specific antibodies are detected in the serum of humans for decades
(78). Additionally, the humoral immune response generates non-immunoglobulin
secreting memory cells to the antigen that confer a quick and robust response upon
subsequent encounters with the antigen.
The development of the humoral immune system begins in the bone marrow from
hematopoietic stem cells (HSCs) (81) (Figure 1). HSCs have the potential to differentiate
into multiple lineage specific progenitors, including the common lymphoid progenitor
(CLP) (48). CLPs undergo further differentiation to become pre-pro B and pro-B cells,
which is dependent on cell contact and additional factors provided by the
microenvironment (26, 32, 35). During this process, pro-B cells undergo
immunoglobulin heavy chain VDJ gene rearrangement. Upon successful rearrangement,
1

2

these now pre-B cells express the pre-B cell receptor and begin rearranging their light
chain. Immunoglobulin gene rearrangements are essential for the generation of a diverse
antibody repertoire. After functional pairing of the heavy and light chains, immature B
cells express IgM on their surface. Immature B cells will leave the bone marrow and
migrate to the spleen to continue their maturation before re-circulating to the secondary
lymphoid tissues as mature B cells ready for antigen encounter. Mature B cells may
encounter their specific antigen and become activated through interactions with an
antigen-specific T cell (31). At this stage, an activated B cell can become either a
memory B cell or a plasmablast, which is the precursor for antibody producing plasma
cells (1). Typically, maturation and differentiation occurs when an activated B cell enters
a germinal center reaction and undergoes affinity maturation and isotype switching (52)
(Figure 1).
After antigen encounter, some antigen-specific plasmablasts migrate from the
spleen to the bone marrow, where they differentiate into long-lived plasma cells (15, 69,
79) (Figure 2). Appropriate migration into the bone marrow requires the interaction
between the chemokine CXCL12 and its cognate receptor CXCR4 that is found on
plasmablasts (33, 67). CXCL12 is produced by the bone marrow microenvironment,
which is thought to generate a chemokine gradient that directs plasmablasts to the bone
marrow. Once plasmablasts migrate to the bone marrow, they lose their ability to
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respond to CXCL12 (34). However, CXCL12 regulated chemotaxis is sufficient to direct
plasmablasts to their appropriate bone marrow niches where they differentiate into
plasma cells (see second half of Figure 2). When they have properly migrated and are
appropriately situated, newly generated plasma cells produce hundreds to thousands of
immunoglobulin molecules per minute (12, 88).
Long-Lived Plasma Cells
The half-life of an antibody is approximately three weeks (88). This suggests that
the specific antibody production needs to be continuously replenished by plasma cells.
Since serum concentration of antigen-specific antibodies remains constant for years after
exposure, the source of antibodies has been controversial (3, 78). The controversy has
caused scientists to be in one of two camps of thought in regard to the source of these
protective antibodies. The first group believes that the long-term antibody protection is
governed by long-lived plasma cells. The second group hypothesizes that plasma cells
are not long-lived, but rather continuously generated by memory B cells.
In order to provide adequate protection, the body generates antigen specific
plasma cells upon antigen exposure. Proliferation assays, utilizing thymidine
incorporation, demonstrated that the plasma cells in the secondary lymphoid tissues were
different from those in the bone marrow (37). It appears that two distinct plasma cell
populations are generated after antigen encounter (37). The first population consists of
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the short-lived plasma cells (37, 39, 40). These cells are formed in the secondary
lymphoid tissue within a week of antigen encounter. They provide a primary rapid
response. However, their antibodies have low affinity for the antigen, so additional
protection is likely needed (39, 40). Additional immunity and protection is facilitated by
the long-lived plasma cells, which reside predominately in the bone marrow (6, 20, 59,
79). Long-lived plasma cells are generated in germinal center reactions in the secondary
lymphoid tissue and are independent from the memory B cells that are also generated in
this response (18). Germinal center-derived plasma cells require more time to mature
compared to short-lived plasma cells, and they produce antibodies with high affinity.
Although distinct populations of plasma cells were discovered in the mouse, the
lifespan of long-term plasma cells was not determined until the mid 1990s (59, 79).
Bromodeoxyuridine (BrdU) incorporates into newly synthesized DNA and is used to
detect proliferating cells (59). BrdU experiments allowed the researchers to label cells
generated immediately after immunization. Plasma cells generated during the
immunization would be labeled since plasma cells are terminally differentiated and do
not proliferate, while pre-existing plasma cells generated by prior antigen exposure would
not be labeled. The BrdU approach determined that long-lived plasma cells remain in the
bone marrow of mice for hundreds of days after immunization, with a lifespan similar to
memory B cells. The lifespan similarity led to the speculation that long-lived plasma
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Figure 1: B cell development in the bone marrow. The bone marrow is the site of B
cell development. Hematopoietic stem cells (HSC) are generated in the bone marrow and
can give rise to multiple cell types, including the common lymphoid progenitor (CLP). A
CLP can become a B cell, and B cells require multiple stages of maturation, to become an
antigen-specific immature B cell.
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Figure 2: The generation, migration, and maintenance of plasmablasts.
Upon encountering their cognate antigen, B cells undergo a germinal center reaction,
leading to the production of antigen-specific memory B cells and plasmablasts.
Plasmablasts can then enter the circulation and migrate to the bone marrow, due to their
attraction to the chemokine CXCL12. Once situated in the niche, plasmablasts mature
into terminally differentiated plasma cells and produce antibodies.
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cells are actually maintained by memory B cells in the bone marrow. To determine what
role, if any, memory B cells play in humoral immunity, mice were treated with CD20
mAb (18). CD20 mAb depletes mature and memory B cells, while leaving plasma cells
intact. If memory B cells contributed to the survival and maintenance of long-lived
plasma cells, then a decrease was expected in immunoglobulin production upon CD20
mAb treatment. However, depletion of memory B cells did not decrease the production
of serum antibodies, demonstrating that antibody titers are maintained by long-lived
plasma cells, not memory B cells.
Bone Marrow Microenvironmental Niches for Plasma Cells
Many cell types, including committed B-lineage cells, require specific niches
provided by the microenvironment that offer cell-cell contact and other signals important
for maintenance and survival. In particular, plasma cells require extrinsic survival signals
for their long-term maintenance (73). In vitro co-culturing experiments demonstrated that
plasma cells are unable to survive in the absence of additional bone marrow cells (11,
62). Research suggests that the bone marrow reticular stromal cell may provide this
plasma niche. The reticular stromal cell is a form of connective tissue cell that have
highly branched (dendritic) processes in vivo and fibroblastic morphology in vitro. In
secondary lymphoid tissues, like the lymph nodes and spleen, stromal cells make contact
with lymphocytes and generate an extracellular- matrix to provide additional structural

8

support (42, 71). This contact is also suggested in the primary lymphoid tissue as well
(71). The evidence that reticular stromal cells may provide the plasma cell niche is partly
due to their ability to produce copious amounts of CXCL12 (9). The engagement of
CXCR4 on plasma cells, with its ligand CXCL12 has a positive effect on plasma cells in
vivo. For when this interaction is inhibited, such as in experiments deleting CXCR4,
there is a decrease in the number of mature plasma cells found in the bone marrow (84).
This suggests that CXCL12 is required for plasma cell homeostasis in the bone marrow
(84). These receptor depletion experiments may recapitulate what occurs in vivo. During
inflammation at a secondary site, the production of CXCL12 is decreased (86). This
decline in CXCL12 causes plasma cell numbers to decline in the bone marrow, and
increase at the inflamed sites in the host (57). Additionally, Tokoyoda’s work supported
the hypothesis of reticular stromal cells providing a plasma cell niche by demonstrating
that the majority of IgG+/CD138+ plasma cells were in direct contact with CXCL12+
stromal cells (84). In addition to providing niches for plasma cells, CXCL12+ stromal
cells also support early B cell lymphopoiesis (44). Overall, these experiments suggests
that bone marrow-derived stromal cells likely provide in vivo plasma cells niches, and
would be an ideal candidate for use in in vitro culturing systems.
Besides reticular stromal cells, dendritic cells may also comprise a plasma cell
niche in the bone marrow (27, 75, 83). Experiments assessing splenic CD11c+ dendritic
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cells demonstrated that they are associated with newly generated plasmablasts (27).
Phenotypically similar dendritic cells have been characterized in the bone marrow (75).
Elegant experiments eliminating the bone marrow-derived dendritic cells lead to the
prevention of antigen-specific IgM producing plasma cells in vivo (75). This outcome
demonstrates that dendritic cells contribute to plasma cell maintenance in the bone
marrow.
Although two potential microenvironmental niches (reticular stromal cells and
dendritic cells) have been elucidated, many questions remain unanswered in regard to the
extrinsic signals and niches that are required for plasma cells in vivo. First, do reticular
stromal cells and dendritic cells represent the only two elements of the plasma cell niche,
or do other cell types play a role? Second, since plasma cells accumulate with age, are
the niches limitless or are they confined to a finite number in the bone marrow? Third,
since antigen-specific antibodies are found in the circulation years after antigen exposure,
do plasma cells compete to remain in their survival niche or is their residence there
permanent? Lastly, are all bone marrow microenvironments equivalent or distinct based
on its location in the animal?
Changes in the Bone Marrow and B Cell Repertoire With Age
As we age, many organ systems begin to decline. Much scientific effort has
focused on understanding how aging impacts the immune system. In regard to the
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humoral immune response, aging negatively impacts the antibody response, leading to a
decline in the antibody diversity that limits the overall effectiveness of the response (30,
53, 80). In addition to intrinsic alterations in the production of immunoglobulin, changes
in the microenvironments that support the humoral part of the immune system, occur in
the older host (30, 50, 82).
One noticeable change in the murine bone marrow is that the residing B cell
population deviates with age (41) (Figure 3). Studies characterizing the percentage of
cells at each developmental stage in the bone marrow demonstrate an age-related shift
from an immature to a mature phenotype (41). Even though the aged bone marrow
microenvironment favors an increase in mature B cells and plasma cells, the antibody
repertoire is less diverse compared to younger mice (53). This is due to the reduced
somatic hypermutation during the VDJ rearrangement of the immunoglobulin heavy
chains generated in aged antibody producing cells (plasmablasts and plasma cells) in both
the bone marrow and the spleen (53). Similarly, antibodies in aged human subjects have
lower avidity and affinity for their specific antigen than those from younger individuals
(46, 47). Lower avidity and affinity negatively affects the interactions of antibodies to
their cognate antigen, which in turn decreases their protective capabilities. In some cases,
the decline in antibody diversity is associated with a decrease in total serum antibodies
(30, 47).
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A decrease in circulating antibodies contributes to inefficient responses against
invading pathogens. Various groups have observed that plasma cells accumulate in the
aged bone marrow (91). However, work assessing newly generated antigen specific
antibody forming cells (AFCs), which contain both plasmablasts and plasma cells,
demonstrated a decrease in overall generation of AFCs and AFCs in the aged bone
marrow after immunization (30). These data suggest that the evident plasma cell
accumulation may be comprised more of plasma cells generated earlier in life. Since
follicular B cell maturation depends on the help provided from CD4+ T cells, research
has focused on determining whether the decline in the humoral response with age is due
to a deficiency in CD4+ helper T cell function. Song et al. demonstrated that there was a
decrease in CD4+ helper T cell function with age (80).
Investigators have addressed changes in the secondary lymphoid tissue, in
particular, the germinal center events that occur there. The secondary lymphoid tissues,
such as spleen, are sites of B cell maturation and activation due to their exposure to
antigens and formation and completion of germinal center reactions. In the aged mouse
model, there is a decline in the generation of plasmablasts and plasma cells after
immunization (30, 31). A potential explanation for the decrease in the production of
AFCs after immunization is that germinal center reactions decrease with age. Assessment
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Figure 3: Percentage of B-cell subsets within the total bone marrow B-cell
population. Bone marrow was flushed from young (2 month old, N=56) and old (22
month old, N=51) BALB/c mice and were stained with various antibodies. B cell
phenotypes were assessed and quantified by flow cytometry analysis. pro-B,
B220lo/CD43+/IgM±; pre-B, B220lo/CD43±/IgM±; immature B, B220lo/CD43±/IgM+;
mature recirculating, B220hi; plasma cells, B220neg/CD138+. Data courtesy of Kara
Johnson, PhD (41).
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of splenic sections after immunizations demonstrated that there is a decline in both the
formation of germinal centers and the number of germinal center B cells, suggesting that
aged spleen cannot properly facilitate this response (30).
The impact aging has on the immune system is likely affected by changes in the
bone marrow itself. After immunization, the bone marrow becomes the primary site of
antibody production. So, changes in the marrow microenvironment could be detrimental
to this arm of the humoral immune response. In addition to changes to the plasma cell
compartment, age related changes in the bone marrow microenvironment affect Blymphopoiesis. Adequate antibody responses require efficient immunoglobulin gene
rearrangement, which is mediated by RAG 2, the enzyme important in rearrangement and
recombination of the immunoglobulin and T cell receptor. Bone marrow chimeras
determined that the decreased RAG 2 and recombinase expression and activity was
controlled by extrinsic factors contributed from the bone marrow itself (49, 50). Work
done in our lab determined that there is a decrease in early B cells in aged long-term bone
marrow cultures (LTBMC) (82). This decrease was caused by insufficient IL-7 produced
from the bone marrow stromal cells, which is required for the survival of early B cells.
Additional work using LTBMCs demonstrated that these aged stromal cells also generate
increased concentrations of CXCL12 (Su et al. in preparation). Changes in the
production of some bone marrow derived growth factors may represent a shift in the
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types of niches present in the aged bone marrow. The alteration of extrinsic signals and
growth factors may explain why there is an accumulation of long-lived plasma cells in
the bone marrow of aged mice, seemingly at the expense of early B cell subsets (Figure
3).
Femur versus Sternum
Vertebrates rely on their skeleton to provide structural support and protection of
their organs. Additionally, bones can harbor the bone marrow, which is the major site of
hematopoiesis (45). The skeleton is comprised of structurally different bones, based on
their development and overall function. Cortical bones, such as the femur, support the
body with its strong and durable outer shell (cortex). Cortical bones develop from the
growth plates by cartilage growth and the overall calcification of the cartilage. Encased
by the cortical bone of the femur is the bone marrow. At birth, the red bone marrow is
the site of hematopoiesis, which produces red blood cells, platelets, and white blood cells
(45). By the time a human reaches adolescence, the human femoral bone marrow
converts from red marrow to yellow marrow, which is comprised of adipocytes (17, 25).
This reduction in hematopoiesis is due to the conversion of the marrow as well as the
decline in hematopoietic stem cell (HSC) function (87).
In contrast to the femur, the sternum is a long membraneous flat bone.
Membraneous bones typically develop from clusters of mesenchyme, rather than
cartilage. Mesenchyme is an example of undifferentiated reticular connective tissue,
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which is a form of loose connective tissue. The sternum protects the chest from trauma
and houses red marrow. However, there are two notable differences between the bone
marrow of the sternum and that of the femur. The sternum does not undergo conversion
from red to yellow marrow, and remains a site of hematopoiesis for the duration of life.
Additionally, the sternum in the mouse is formed in segmented joined with small
cartilage plates, while the femur is continuous (Figure 4). This discontinuation of
marrow may alter the B cell niches that reside in the sternum bone marrow. Despite
these differences in the compartmentalization of bone marrow, Trubowitz et al.
demonstrated that the sternum harbors similar vascular circulation to the femur,
demonstrating that circulation is not a factor in the potential difference in niches (85).
This result suggests that regardless of the differences in the structure and composition of
these two sites, hematopoietic cells are able to migrate to and from the bone marrow in a
similar manner.
Since these two bone marrow sites differ in regard to the balance of red marrow
and compartmentalization, it suggests that the total body bone marrow in adults is not
uniformly distributed. Research in Dr. Phong Le’s lab has demonstrated that here is an
increased expression of the transcription factor Foxn1 in the sternum compared to the
femur in Foxn1 transgenic mice (Zook et al. in preparation). Mutations in this
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Figure 4: The organization of the sternum bone marrow.
Hematoxylin and eosin staining was used to illustrate the segmentation of the sternum
bone marrow. The bone marrow (dark purple) is segmented by cartilage (light pink) in
this 24 month wild-type C57Bl/6 mouse. Sternum sectioning and staining performed by
Erin Zook and Shubin Zhang. (6.3x magnification)
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transcription factor correlate with deficiencies in the T cell compartment of the immune
system. This increased expression of Foxn1 may explain why the sternum has an
increased frequency of early lymphoid progenitors, like the common lymphoid progenitor
(CLP), in these mice (Zook et al. in preparation). Though Zook’s current research has
initiated the exploration of the differences in bone marrow cellular populations, my
document is one of the first to look at the sternum and its resident B cell compartment.
Plasma Cell Signals for Survival or Immunoglobulin Regulation
An efficient antibody memory depends on the ability of plasma cells to survive
for long periods of time in the bone marrow. Plasma cell survival is governed by soluble
factors and cell contact provided by the local microenvironment (2, 5, 7, 10, 11, 15, 18,
21, 24, 27, 28, 30, 37, 38, 43, 58-60, 62-64, 68). This is predominately provided by the
reticular stromal cells (10, 11, 42, 62). However, the heterogeneity of the bone marrow
suggests contributions from additional cell types. A summary of the important plasma
cell signals for this thesis are listed in Table 1.
The factors secreted by reticular stromal cells have been studied to determine their
contribution to plasma cell homeostasis. One well known factor is the chemokine
CXCL12. Upon engagement of CXCL12 to its receptor CXCR4, plasmablasts and
plasma cells migrate towards the bone marrow, which has an increased concentration of
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Receptor/Surface
Molecule

Type

Function

References

CD138

Transmembrane
heparan sulfate
proteoglycan

Cell signaling, and can
bind to APRIL

Ingold et al. 2005

CXCR4

Chemokine receptor for
CXCL12

Important in proper
homing to bone
marrow, and other
CXCL12 rich areas

Hauser et al. 2002,
Minges Wols 2007,
Cenci et al. 2007

TACI

Transmembrane protein
that binds to TNF
family ligands

Important in cellular
activities like antibody
production, plasma cell
survival, and
homeostasis

Chu et al. 2007,
Darce et al. 2007, Xu
et al, 2001, Mackay
et al. 2007

TLRs

Single membrane
spanning receptor

Antibody production
due to these signals
from foreign antigens

Dorner et al. 2009,
Genestier et al. 2007,
Ingold et al. 2005

Table 1: Receptors and other plasma cell surface molecules important in plasma cell
signaling.
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this chemokine, compared to the secondary lymphoid tissues (34, 60). Though CXCL12
controls the accumulation of plasma cells to the bone marrow, it does not appear to
modify immunoglobulin production by itself (60, 67). Though isolated plasma cells
cultured with CXCL12 produce and secrete antibodies, greater concentrations are
generated when plasma cells are incubated with another stromal cell-derived factor,
interleukin-6 (IL-6) (60). IL-6 is produced by multiple types of cells, and is found in
higher concentrations in the secondary lymphoid tissue compared to the bone marrow
(60). Though IL-6 is not as highly expressed in the bone marrow, IL-6 is required for the
survival of plasma cells in vitro (11). However, IL-6 knock-out mice had similar
numbers of plasma cells compared to wild type (11). This suggests that IL-6 is sufficient
but not the only factor required for plasma cell homeostasis.
Recently, APRIL was discovered as a factor important in bone marrow plasma
cell function and maintenance. This tumor necrosis factor (TNF)-family member is
expressed in both the membrane-bound and soluble form and is produced primarily by
innate immune cells, like monocytes (56). APRIL is typically found as a homotrimeric
transmembrane protein, which is proteolytically cleaved, and upon multimerizing with
additional APRIL proteins, it can engage its cognate receptors. APRIL can bind to both
the BCMA (B Cell Maturation Antigen) and TACI receptors that are expressed on
various B cell types (54). TACI is expressed on all peripheral B cells, including plasma
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cells, while BCMA is restricted to plasma cells alone (13, 16). In addition to APRIL,
BCMA can also be activated when it binds BAFF (B cell Activating Factor) (54) .
APRIL can also bind to heparin sulphate proteoglycans (HSPG) like syndecans, which
are expressed on plasma cells (38).
Studies utilizing BCMA knock-out mice demonstrated that BCMA is important
for long-term plasma cell survival (68). The researchers demonstrated that BCMA
knock-out mice had a significant decrease in the number of antigen-specific ASCs in the
bone marrow, for seven weeks after immunization. Our lab, and others, determined that
transcripts for one of BCMA’s ligands, BAFF, are expressed in very low amounts in the
total bone marrow or specifically, the stromal cells (5, 60). This finding suggested that
BCMA’s other ligand, APRIL, may be an important signal for in vivo plasma cell
survival in the bone marrow. Additional experiments determined that in the absence of
endogenous APRIL, there was a decrease in the number of plasmablasts and plasma cells
in both the primary and secondary lymphoid tissue (5, 7). APRIL can also affect
antibody diversity by regulating class switching (5). APRIL knock-out mice had
decreases in isotype class switching, in particular, switching to the IgA isotype (5).
Once it was determined that APRIL-dependent signals positively regulated
plasma cell survival, researchers next wanted to determine which receptor, BCMA or
TACI, mediated the plasma cell survival. Conflicting reports have emerged in regard to
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BCMA’s role in APRIL-mediated signaling. Xu et al. found that in BCMA knock-out
mice, there was no negative effect on immunoglobulin production or germinal center
formation compared to wild-type mice (90). However, later studies illustrated a
significant decline in antigen specific long-lived plasma cells in the bone marrow (68).
These data suggest that BCMA does not play a prominent role in the formation of plasma
cells, or their function, but rather their survival in the bone marrow. Research regarding
TACI’s role in APRIL-mediated responses, has been more straight-forward. In mice
deficient in TACI, there is an increase in B cell proliferation, indicating that TACI
regulates B cell homeostasis (55). Specifically, the lack of TACI lead to a significant
decrease in IgA class switching, demonstrating that the previous observations about
APRIL’s regulation were mediated by the TACI receptor on plasma cells (55, 74).
Cell regulation is complex and causes multiple factors to contribute to similar
cellular functions. Another signaling cascade that regulates plasma cell function is
provided by toll-like receptors (TLR). These pattern recognition receptors (PRR)
recognize molecular patterns commonly found on pathogens and were originally
identified on cells of the innate immune system (21). Studies assessing TLR mRNA
levels in various B cell populations determined that all B cells express some TLR
transcripts; however, the profiles varied depending on the particular B cell subsets (21).
Both human peripheral blood and tonsil residing plasma cells express TLR1-TLR9 (8,
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21). Engagement of these TLRs led to an increase in both antibody production and
secretion (21, 28, 43). In mouse, TLR agonists signal for the differentiation of various B
cell subsets to differentiate into plasma cells (28). Similar to human plasma cells, TLR
signaling leads to an increase in immunoglobulin secretion and expression of plasma cell
transcription factors (like Blimp-1) in B cells. This response occurs in the secondary
lymphoid tissue, which could lead to the generation of long-lived plasma cells in the
murine bone marrow. The signals could be due to TLR signaling itself, or to
subsequential signaling after TLR engagement. When terminally differentiated plasma
cells were exposed to TLR7 and TLR9 agonists, there was an up-regulation of the TACI
receptor (43). These results demonstrated that TLR signaling not only affects the innate
immune response, which is non-specific, but also contributes to the adaptive immune
response.
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Summary
The generation and survival of plasma cells is essential for providing an
immediate and long lasting humoral protection to foreign antigens. Upon activation,
antigen-specific B cells differentiate into plasmablasts and migrate to the bone marrow.
There, they further differentiate into plasma cells in response to extrinsic factors
contributed by the bone marrow microenvironment. These plasma cells reside in niches,
comprised of stromal cells and dendritic cells, and provide protection to the host by
producing high concentrations of antibodies.
The bone marrow represents a dynamic microenvironment, one which can change
its cellular composition and production of extrinsic factors. Marrow is housed in both
cortical and membranous bones. Cortical marrow changes as the host ages. Although
plasma cells accumulate in bone marrow thoughout a lifetime, the ability of new plasma
cells to adequately protect diminishes, due to their production of low affinity and less
diverse antibodies. Understanding the contribution the bone marrow provides for this
response and how it may change as the host ages is important in modifying vaccines to
stimulate efficient responses in the elderly.
The purpose of my thesis is to investigate two bone marrow sites and determine
their similarities and differences in regard to plasma cell survival and immunoglobulin
production. This thesis will look at the impact bone marrow location and age have on the
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plasma cell frequency and in vitro survival. Overall, my experiments will help
determine if the previous research on femur-derived plasma cells represents a universal
paradigm or applies only to the plasma cells residing in the femur. This knowledge will
help aid in the quest to understand the mechanisms and factors required for an adequate
humoral attack in response to a foreign antigen.

CHAPTER II
METHODS
Mice
Young (6 week) and old (18 months) female BALB/c mice were purchased from
Harlan (Indianapolis, IN) and Charles River/National Institute of Aging (NIA) (Bethesda,
MD), respectively. Once received, mice were housed at the Comparative Medicine
Facility at Loyola University Medical Center under standard pathogen-free conditions.
Mice were sacrificed by CO2 inhalation. Aged mice with visible tumors or enlarged
spleen were not used in these studies.
Antibodies
The following antibodies were used throughout these studies: PerCP rat antimouse CD45R/B220 (0.2 mg/ mL; RA3-6B2, BD Biosciences, San Jose, CA), PE rat
anti-mouse CD138 (syndecan-1) (0.2 mg/ mL; 281-2, Pharmingen, San Jose, CA), APC
conjugated rat anti-mouse TACI (CD267) (0.2 mg/mL; eBio8F10-3, e-Bioscience, San
Diego, CA), goat anti-mouse IgG/A/M-FITC (Invitrogen, Carlsbad, CA), affinity
chromatography purified rat anti-mouse IgM (11/41, BD Biosciences), affinity
chromatography purified mouse IgM isotype control (11E10, e-Bioscience), which was
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used to generate a standard curve for an ELISA, and biotin rat anti-mouse IgM (R6-60.2,
Pharmingen).
Preparation of femoral and sternum bone marrow
Both tibias and femurs were removed from each mouse. Bone marrow was
flushed with a 25-gauge needle attached to a 10 ml syringe filled with long-term bone
marrow (LTBMC) media. The media consisted of RPMI 1640 (Lot 15040254,
Mediatech, Manassas, VA), supplemented with 5% FBS (Lot ARE26454, HyClone,
Logan), 1% L-glutamine (Cellgro, Manassas, VA) 1% penicillin/streptomycin (Cellgro)
and 5x10-5 M β-Mercaptoethanol (β-ME) (Fisher Scientific, Pittsburgh PA). Total bone
marrow cells were quickly vortexed and passed through a syringe and 25-gauge needle to
break up any cell clumping. Cells were centrifuged at 1100 rpm for seven minutes and
cell pellets were resuspended with 5 ml media and counted by trypan blue exclusion.
Typically, two femurs and two tibias from a single mouse yield approximately 45 million
live cells, though this number varies with age.
The sternum was removed from each mouse and muscle was removed with
forceps. Bone marrow was flushed out with a 25-gauge needle attached to a 10 ml
syringe filled with LTBMC media. Since the sternum is segmented, after a section was
flushed, the sternum was cut to reach the next marrow section. After flushing, the cells
were centrifuged and pellets were resuspended with 1 ml of media and counted by trypan
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blue exclusion. Typically, a single sternum yields approximately ten million live cells,
although this number varies with age.
Enumeration of plasma cells in cytodots of total bone marrow cells
Bone marrow cells were harvested from wild type young (2-3.5 months) and old
(18-24 months) BALB/c mice. Two hundred and fifty thousand bone marrow cells were
resuspended in two hundred and fifty microliters of RPMI and cytospun onto each slide
(Thermo Scientific Shandon Cytospin3). Cytodots were either stained immediately or
dessicated and stored at 4oC. Cytodots were fixed with 95% ethanol/5% acetic acid and
stained with the FITC conjugated goat anti-mouse IgM/A/G antibody at a concentration
of 0.2 µg/dot and mounted with a coverslip. Approximately 1000 total cells were counted
by phase contrast, and plasma cells were assessed and scored by immunofluorescence
(Leitz Diaplan Microscope, magnification 20X).
Phenotyping of bone marrow
After the bone marrow was harvested, 1x106 bone marrow cells were stained with
rat anti-mouse B220-PerCP, rat anti-mouse CD138-PE and rat anti-mouse TACI-APC
antibodies, each at a 1:50 dilution (4 µg/mL) in FACS staining buffer. FACS staining
buffer consists of Hank’s Balanced Salt Solution supplemented with calcium and
magnesium, and 5% heat inactivated fetal calf serum and 0.1% sodium azide. Cell
suspensions were incubated on ice for 20 minutes. After incubation, cells were washed
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with 1 ml of staining buffer. Cells were then centrifuged, at 1100 rpm, and resuspended
in 1ml of 1x PBS. After a second centrifugation, cells were fixed with 1%
paraformaldehyde in PBS. The cells were stored at 4oC overnight and flow cytometry
analysis was performed the following day using the BD FACSCanto flow cytometer
(Franklin Lake, NJ) and FlowJo software.
Stromal cell isolation
Whitlock-type long term bone marrow cultures that support B-lymphopoiesis
(LTBMC-B) were generated from the bone marrow from either femoral bones and
sternum of individual young (age 6-10 weeks) or old (age 15-24 month) BALB/c mice.
Femoral cells were plated at a density of 13x106 cells/100 mm plate (Corning, Inc.,
Corning, NY) and grown in LTBMC media. Sternum bone marrow cells were plated at a
density of 6x106 cells/60 mm plate (Corning, Inc., Corning, NY) and grown in LTBMC
media. Although cultured in different sized plates, the adherent growth of cells from
femur and sternum appeared similar in culture, and cells from each marrow source
reached the desired confluency around week four.
Approximately six weeks following culture set-up, stromal cells were FACSsorted into individual wells of flat-bottomed 96-well plates (Corning, Inc., Corning, NY)
at 1x104 cells/well. Prior to sorting, LTBMC-B cultures were incubated for 3.5 hours
with 5µg/ml (in a total of 2.5 mL LTBMC-media) 1,1’-dioctadecyl-3,3,3’,3’tetramethylindo-carbocyanine perchlorate-labeled acetylated low density lipoprotein
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(DiI-ac-LDL) at 37oC (Biomedical Technologies Inc., Stoughton, MA), in order to
separate macrophages from stromal cells. After incubation, lymphocytes were removed
by the addition of 1x ethylenediamine tetraacetic acid (EDTA), in a total volume of 3 ml.
Calcium chelation allows for the disengagement of lymphocytes from stromal cells.
Adherent cells were then treated with 0.25% trypsin-EDTA for five minutes and
harvested, after neutralization with LTBMC, by gentle scraping with a silicon rubber
policeman. Adherent cells were then resuspended in FACS sorting staining buffer, which
consists of RPMI 1640, 5% FCS, L-glutamine, gentamycin, and 5×10−5 M βmercaptoethanol. Cells were brought to the FACS facility and were sorted based on high
forward and side scatter and the inability to take up DiI-ac-LDL (Figure 5).
Plasma cell isolation
For each isolation, bone marrow was flushed from three individual wild type aged
mice, pooled, and counted as previously described. Total bone marrow cells,
approximately 130 million cells from three mice, were incubated with rat anti-mouse
CD138-PE at a 1:40 dilution (0.005 mg/mL) in staining buffer [Hanks BSS with Ca2+,
Mg2+ (Fisher Scientific), 5% HI FBS (heat inactivated FBS), and 2mM EDTA]. After a
twenty minute incubation on ice, cells were washed in buffer and incubated with anti-PE
beads, at 5 µl per million cells (Miltenyi Biotec). After washing, CD138 positive cells
were then enriched by column isolation (Miltenyi Biotec MACS Separation Column MS
MiniMACS Columns). Column isolation requires an appropriate apparatus: a column
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Figure 5: Stromal Cell Profile. After incubation in DiI-ac-LDL, adherent LTBMC cells
were taken to the FACS facility to be sorted based on their ability to take up ac-LDL and
overall size and granularity. Cells are first sorted and gated based on moderate FSC and
SSC (A). Gating eliminated any extremely low FSC and SSC cells to reduce the number
of dead cells. Desired stromal cells where ac-LDL negative with a moderate granularity
(SSC) (B).
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attached to a separator, washed with buffer alone. Once the column flow is established,
500 µl of the cell suspension is added to the column. This is repeated until the entire
suspension is passed through the column. To remove residual PE-negative cells, the
column was washed two times before the positive cells were plunged into a conical tube.
Column-isolated cells were then further purified by fluorescence-activated cell sorting
(FACS) for CD138 positive cells. The approximate recovery of CD138 positive cells
from 120 x 106 cells was 7.5 x 104.
Co-culturing of stromal and plasma cells
Isolated plasma cells from wild type bone marrow were added to FACS-sorted
stromal cells at a density of 5x103 plasma cells per well, with 104 stromal cells into 96well flat-bottom plates. The total volume was then adjusted to 150 µl. Cells were
cultured at 37oC and 5.0% CO2 for approximately three weeks. Supernatants were
collected at various time points and fresh media was added after collection. Supernatants
were previously collected at indicated time points and were frozen at -20oC until they
were tested by ELISA.
Measurement of immunoglobulin by Enzyme-linked immunosorbent assay (ELISA)
Nunc U-bottom 96 plates (Fischer Scientific, Hanover Park, IL) were coated
overnight with 2 µg/ml rat anti-mouse IgM (BD Bioscience) in 1x PBS with 0.02%
sodium azide. Plates were then blocked with 1x PBS/1% BSA at 37oC for one hour to
prevent nonspecific binding.

To generate a standard curve, each plate contained two-
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fold serial dilutions of isotype specific standards, ranging from 1000 ng/ml to 1.95 ng/ml,
at a total volume of 40 µl per well. As a negative control, media alone was used. Once
the supernatants were incubated for two hours at 37oC, the detection antibody (biotin
conjugated rat anti-mouse IgM) was added to each well at 1 ug/ml for two hours. After
washing the plate, streptavidin-conjugated alkaline phosphatase was added for 30
minutes at 37oC. The assay was developed by the addition of p-nitrophenyl phosphate
(PNPP) (Sigma-Aldrich) diluted in 1 mg/ml in 10mM diethanolamine, 0.5mM MgCl2, pH
9.5. Plates were read using a BioTek Synergy HT plate reader (Winooski, VT) at optical
density of 405 nm. Results were reported, based on the linear part of the standard curve,
in ng/mL.
RNA isolation and Real Time PCR analysis of APRIL
RNA was isolated from either total bone marrow or spleen of young and aged
mice. Total bone marrow, from either femur or sternum, was isolated as described above,
and cell pellets ranged from 1 x106 -10x106 cells/pellet. Spleens were cut into fourths
and one-fourth was weighed and used for RNA isolation. RNA was isolated from the
homogenates using the Qiagen RNeasy kit. Spleens were homogenized using a rotor
stator homogenizer, suspended in Buffer RLT (Valencia, CA), which lyses the cells to
obtain RNA. After homogenizing cells, 70% ethanol was added to the cells to optimize
binding of RNA to the RNA membrane provided in the kit. After cell lysates were added
to the membrane, the membrane was washed and centrifuged to eliminate contamination.
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After washing, RNA was eluted and the concentration was estimated by NanoDrop
technology (Thermo Scientific). RNA degradation was assessed by analyzing RNA gels.
cDNA was synthesized using Fermentas RevertAid First Strand cDNA Synthesis Kit
(Fermentas, Ontario, Canada).
Real-Time PCR analysis was performed using a GeneAmp 7300 Sequence
Detection System (Perkin Elmer-Applied Biosystems). SYBR Green PCR Master Mix
(Invitrogen, San Diego, CA), forward and reverse primers at 2.5 µM, UV treated ddH2O,
and appropriate cDNA were added to each sample. As a positive control for APRIL,
RNA was isolated from young and old spleens. Negative controls included samples
without cDNA. A standard curve for HPRT was generated from plasmids containing their
PCR product. These standards underwent ten-fold dilutions ranging from 1 x 101
copies/µl-1 x 105 copies/µl. Controls, standards, and samples were run in triplicate in a
96-well optical reaction plate. Primers were designed using Primer Express Software
(Applied Biosystems) and Primer3 (SourceForge) and purchased by Invitrogen.
Oligonucleotide sequences are shown in Table 2. Primers were generated to span an
intron and ends were assessed to prevent primer binding. The Real-Time PCR was run
on the following settings: one cycle at 50oC for two minutes, one cycle at 95o C for 10
minutes, 40 cycles of denaturing at 95oC for 15 seconds and annealing and elongation for
60oC for one minute. The data were analyzed using GeneAmp 7300 SDS software
(Applied Biosystems). APRIL mRNA expression levels were calculated by determining
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the ratio of the number of copies of APRIL to the number of copies of a housekeeping
gene (HPRT).
Statistical Analysis
Statistical significance between the experimental groups was determined using
unpaired and paired Student’s t test using GraphPad Prism 5 software (San Diego, CA).
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Amplified
Transcript

Oligonucleotide Sequence

HPRT

Forward: AGCAGTACAGCCCCAAAATGG
Reverse: TGCGCTCATCTTAGGCTTTGT

APRIL

Forward: CCCATTCCAAAAACTGGCTA
Reverse: AAAGAATTTGGGGCTGTGTG

Table 2: Oligonucleotide sequence of primers used in Real-Time PCR experiments.
Primers were designed using Primer Express Software (Applied Biosystems) and Primer3
(SourceForge), and purchased by Invitrogen.

CHAPTER III
RESULTS- EXAMINATION OF PLASMA CELLS AND THEIR NICHES IN
FEMORAL AND STERNUM BONE MARROW
Over the last decade, our laboratory developed an interest in the mechanisms
regulating plasma cell longevity in the bone marrow (60, 62, 63). An accumulation of
plasma cells is evident in aged bone marrow compared to the number found in young
mice. Additionally, long-term bone marrow cultures (LTBMC) generated from aged
mice contain resident plasma cells that can survive in vitro for several weeks (62). The
question of whether the aged microenvironment might favor the survival of plasma cells,
both in vivo and in vitro has not yet been addressed. In regard to plasma cell research, the
experimental approach utilized femoral-derived bone marrow. I sought to determine if
the same results would be obtained from sternum bone marrow, which is known to
develop differently than the femoral bone marrow (17, 45). I compared the frequency of
IgM producing plasma cells indirectly via in vitro total bone marrow cultures to assess
any changes in the IgM concentration in either the femur and sternum bone marrow. In
addition, the frequency of plasma cells, in the marrow, was determined using cytodots of
bone marrow cells that were stained with antibodies to IgM, IgG, and IgA. Bone
marrow-derived stromal cells from sternum were evaluated to determine if, similar to
femoral stromal cells, they can maintain plasma cell survival as indicated by
36
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immunoglobulin secretion. This section of results investigates different aged stromal
cells to determine if stromal cells from aged mice facilitate more efficient in vitro plasma
cell niche compared to young stromal cells.
CHARACTERIZATION OF THE PLASMA CELLS FROM FEMORAL AND
STERNUM BONE MARROW
To determine the similarities of these two distinct bone marrow sites, I first
assessed IgM production in cultures of total bone marrow. Previous observations in the
lab found that IgM-secreting plasma cells are present at low frequency in young mice,
and the frequency increases with age. This phenomenon is easily measured by ELISA
for IgM. The concentration of secreted IgM is a reasonable reflection of the abundance
of plasma cells in a bone marrow sample. Bone marrow cells were cultured at two
different cell densities (100,000 and 250,000), and supernatants were collected every
twenty-four hours for three days. Two concentrations of bone marrow cells were chosen
for a specific reason. Obviously, a single concentration would determine if the two sites
were equivalent in IgM production. However, it would be possible that a lower bone
marrow cell concentration would have a detectable difference in antibody production, via
intrinsic immunoglobulin regulation, without an actual decline in plasma cells. Instead,
this antibody difference may reflect a potential rate limiting factor that would be
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compensated for when total bone marrow cells are cultured at a higher concentration.
Thus, the two cell concentrations were used to elucidate between these possibilities.
As I initially predicted, at the lower cell concentration (100,000 cells per well),
there was a difference in detectable IgM secretion between aged femur/tibia and sternum
bone marrow (Figure 6A). At day one, femoral bone marrow had an elevated
concentration of antibodies compared to sternum that quickly declined by forty-eight
hours. In contrast, sternum bone marrow had a more consistent antibody production.
This pattern of antibody production could represent an increase in antibody producing
cells in the sternum, or it could represent a similar frequency of plasma cells but with a
difference in the microenvironments. To address this question, bone marrow cultures
were established at a higher cell concentration (250,000 cells per well) and IgM
concentrations were assessed by ELISA. If the small increase in IgM concentration over
time was due to an increase in IgM producing plasma cells in the sternum, then a
proportional increase in IgM in the sternum compared to the femur would be expected
(Figure 6B). The results demonstrate that when bone marrow cells are cultured at the
greater concentration, an equivalent amount of IgM was detected in the culture
supernatants from both marrow sources at twenty-four hours and throughout the three day
period (Figure 6). These results suggest there may be a similar frequency of plasma cells
in both marrow sites.
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Plasma cell frequency was then directly assessed by staining for intracellular
immunoglobulin. This approach evaluates a representative bone marrow population and
identifies the desired cells with an immunoglobulin-specific antibody (anti-IgM/A/G)
with a fluorochrome. Cytodots were generated by centrifuging 250,000 total bone
marrow cells to slides. Cells were obtained from young (2-3.5 months) and old (18-24
month) wild-type BALB/c femur and sternum bone marrow. Cells were then fixed with
95% ethanol/ 5% acetic acid and stained with a goat anti-mouse IgM/A/G antibody,
conjugated to FITC (Figure 7A).

Total cells were viewed by phase contrast and the

numbers of plasma cells (which are FITC+) were scored using the fluorescent
microscope. The frequency of plasma cells was calculated by dividing the number of
plasma cells by the number of overall cells counted (which were a minimum of 1,000)
and multiplied by one hundred. If the bone marrow sites regulate the specific antibody
production capabilities of plasma cells, then I expect to see a distinct difference in the
frequency of IgM/A/G positive plasma cells (Figure 7A). However, when cytodots from
both bone marrow locations were assessed for plasma cells, there was only a slight
elevation in the sternum (Figure 7B). Additionally, this elevation was not significant
(p=0.081 (young) and 0.133 (old). This approach did allow us to determine that
regardless of the location, there was a significant increase of IgM/A/G positive plasma
cells in the aged marrow (p=0.002). This strengthens our previous unpublished data that
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Figure 6: IgM production in total bone marrow cultures. Total bone marrow cells
were isolated from young (6 weeks) and old (18 months) wild type femur/tibia or sternum
bone marrow. Cells were isolated and counted by trypan blue exclusion and were
incubated at either 100,000 (A) or 250,000 (B) cells/well, in triplicate wells. Supernatants
were harvested and replaced with fresh media daily. Supernatants were assessed for total
IgM production by ELISA. N= 3 for old mice (points are averaged and assessed by
SEM) and N=1 for young mice. Unpaired t-test, p=0.9973 (100,000 cells) and p=0.7128
(250,000 cells). These statistics were done on the overall line per each sample group.
Statistics for (A) day one, by unpaired t-test revealed no significance (P=0.0673)

41

A

B

4

*
*

3
2
1

S
te
rn
um
O
ld

Fe
m
ur
O
ld

Y
ou
ng

Y
ou
ng

S
te
rn
um

0

Fe
m
ur

Percentage IgM/A/G+ cells

% IgM/A/G + Plasma Cells

Figure 7: Frequencies of plasma cells in femur and sternum bone marrow from
young and old mice. Plasma cells were detected by flourescence and confirmed by
morphology (A). 250,000 bone marrow cells were spun onto a slide and were stained
with IgM/A/G-FITC antibodies. Paired t-test statistically assessed the differences in agematched mice ( p= 0.081, young; N=5) and (p=0.133, old; N=8) and unpaired t-test were
used to assess differences between young and old for each bone marrow type (*p=0.002)
(B).
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suggests there is an accumulation of plasma cells in the marrow of aged mice, compared
to the frequency found in young bone marrow. This finding also demonstrates that this
accumulation is a universal phenomenon for the bone marrow and suggests that the
signals and cellular composition that maintain the plasma niches may indeed be similar in
both the femur and sternum.
In order to determine if the increase in sternum plasma cells (although not
significant) represented a consistent trend, plasma cell frequencies were compared in
individual mice using immunofluorescence staining for IgM/G/A. If the increase in
sternum plasma cells represented a common trend, then I expected to see a consistent
increase in plasma cell frequency in the sternum compared to the frequency in the femur
of each individual mouse. As expected, sternum plasma cell frequencies regularly [92%
of the time (11/12 events)] were approximately 0.1-0.2 % higher than those in femur,
regardless of the host’s age (Figure 8). These findings indicate that although the antibody
concentrations became equivalent at the higher cellular concentration (250,000 cells per
well), there appears to be an increased frequency of plasma cells in the sternum on a
mouse to mouse basis.
In summary, the plasma cell compartments appear to be equivalent in regard to
IgM production; however, the sternum houses a higher frequency of total plasma cells
secreting IgM, IgG, and IgA. This suggests that these two bone marrow sites function
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Figure 8: Frequencies of plasma cell and correlation within a single mouse. Total
bone marrow cells were isolated from (A) young (6-8 weeks; N=5) and (B) old (18-24
month; N=7) femur and sternum wild type BALB/c mice. 250,000 cells were centrifuged
to each slide and were stained with goat-anti-mouse IgM/A/G antibody. The investigator
was blinded to the age and organ to not bias the results. Frequency was assessed by
taking the number of plasma cells and dividing it by the total number of cells counted
times one hundred. Each line represents the frequencies of plasma cells in an individual
mouse.
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similarly in the mouse, but may have individual plasma cells with different functional
capabilities. The results may also illustrate a preference for the sternum to harbor more
IgA and IgG producing plasma cells than the femur. Without assessing IgA and/or IgG
production separately, it remains to be determine if the overall production of
immunoglobulin is equivalent or different between the two bone marrow derived plasma
cell subsets.

ARE FEMUR AND STERNUM PLASMA CELLS INTRINISICALLY SIMILAR
IN REGARD TO IN VITRO SURVIVAL?

Now that I have characterized the relative abundance of plasma cells that reside in
the femoral and sternum bone marrow, based on the type of immunoglobulin they
produce, I next sought to determine if these two populations of plasma cells are
intrinsically similar in regard to in vitro survival. In our system, plasma cell survival on
stromal cells was assessed by total IgM production. Stromal cells from long-term bone
marrow cultures were chosen as the feeder cells because prior experiments demonstrated
that stromal cells are capable of supporting plasma cells survival in vitro (62). Aged
femur stromal cells were isolated by sorting via FACS (see materials and methods section
for additional details). One thousand plasma cells, isolated from either aged femoral or
sternum bone marrow, were cultured on duplicate feeder cell layers. Previous data
(Figures 6-8) illustrated that it is possible that sternum plasma cells, although at a higher
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frequency, produced equal amounts of IgM than femur plasma cells. If an intrinsic
difference exists between femur and sternum plasma cells, then I expected to see a
decline in antibody production by sternum plasma cells, compared to femur cells. When
one thousand plasma cells were cultured from either site, there was an initial and
consistent decline in sternum produced IgM in the culture supernatant compared to that
from femur plasma cell cultures (Figure 9). However, both populations survived well
until day twenty one and then diminished rapidly, at the same rate, between days twenty
one and twenty four. This finding suggests that plasma cells, regardless of bone marrow
site, survive similarly in vitro. Although both populations of plasma cells had similar
survival profiles, the femoral plasma cells had an increased secretion of IgM compared to
sternum. The difference in overall immunoglobulin secretion suggested that either
femur-derived stromal cells do not support sternum plasma cells, or that this population
of sternum plasma cells contains fewer IgM producers. To confirm that both plasma cell
subsets were surviving at equivalent rates, microscopy was used two times a week to
monitor cell death by morphology and overall debris. By microscopy, both cell types
appeared to have had similar survival (personal observation).

Overall, these data suggest that the increased frequency of IgM/A/G positive
plasma cells in the sternum (figure 7 and 8) has a slightly decreased amount of IgM
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Figure 9: Comparison of in vitro survival of femur and sternum plasma cells on aged
femoral stromal cells. Stromal cells were isolated from long-term bone marrow cultures
that were generated from aged femur cells. Stromal cells were sorted directly into single
96-wells at a density of 104 cells/well. Two days later, three aged mice were sacrificed
and bone marrow was flushed from the femur and sternum to isolate plasma cells.
Plasma cells were first enriched by magnetic bead isolation using rat anti-mouse CD138PE and anti-PE beads. Next, plasma cells were sorted by FACS, based on size and
fluorescence, and 103 cells were added to each well occupied with stromal cells.
Supernatants were collected at day one and then every three days for twenty-four days
and immunoglobulin concentrations were determined by ELISA. (N=1 experiment)
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production when compared to femoral plasma cells. In addition, in vitro survival of
plasma cells appears to be stable when co-cultured on aged femoral stromal cells. With
similar survival patterns and IgM production, the differences in these two populations
may depict skewing towards IgA and IgG in the sternum. Overall, the results from the
plasma cell frequency and survival experiments may represent intrinsic differences
between plasma cell subsets that correlate with an in vivo difference in the overall
function of the host’s multiple populations of plasma cells.

ARE FEMUR- AND STERNUM- DERIVED STROMAL CELLS EQUIVALENT
IN MAINTAINING PLASMA CELL SURVIVAL IN VITRO?

The previous experiments suggested that despite the increased frequency of
IgM/A/G plasma cells in the sternum, the overall production of IgM from these plasma
cells, isolated from unimmunized mice, is similar. Thus far, all the in vitro experiments
were done using femoral microenvironmental cells (stromal cells). The question remains
if various stromal cells are similar or different in regard to in vitro plasma cell survival. I
attempted to address this question by comparing the response of femoral plasma cells on
either femur- or sternum-derived stromal cells. I chose femoral plasma cells, instead of
plasma cells from sternum for two reasons. Not only has our lab used femoral plasma
cells in numerous studies, which allows us to take advantage of comparisons with
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previous data, but also, the isolation of femoral plasma cells is more routine compared to
sternum.

As shown in Figure 9, stromal cells from aged femur are capable of maintaining
plasma cell survival. I assessed plasma cell survival on either young (6 week) or aged
(15 month) femur- or sternum-derived stromal cells. Stromal cells were isolated from
long-term bone marrow cultures maintained in our lab. After they were sorted and
aliquoted into 96-well plates seventy-two hours earlier, sorted femoral plasma cells were
added to each well and supernatants were collected to assess plasma cell IgM production.
The first question addressed was, “are aged femoral stromal cells comparable to young
stromal cells in ability to maintain plasma cell survival in vitro?” Using plasma cells
from a single isolation, I could assess if the various aged stromal cells are capable of
maintaining their survival. If the age of femoral stromal cells positively affects plasma
cell survival, then I expected to observe increased immunoglobulin in supernatants from
plasma cell cultures with aged stromal cells compared to ones cultured with young
stromal cells. As predicted, the concentration of antibody was increased and an elevated
level of IgM was maintained throughout the experiment when plasma cells were cocultured with stromal cells from aged mice (Figure 10). Considering that prior
experiments utilized young stromal cells, we were surprised that cultures containing
young stromal cells had a rapid decline in IgM production after day one (62). The
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decline in IgM continued for the duration of the experiment, and IgM concentrations
were only slightly elevated when compared to supernatants from plasma cells alone. This
suggests that young stromal cells provide less support to plasma cells than aged stromal
cells. My data support prior findings that there is an accumulation of plasma cells in
aged femur compared to young and suggest that this accumulation may be due to the
maturation of stromal cells. The enhanced support of plasma cells by aged femoral
stromal cells led me to question if this was a common trait of all bone marrow stromal
cells. Since there was an accumulation of plasma cells in both femoral and sternum bone
marrow sites, I predicted there would also be a similar age-related difference in plasma
cell maintenance using stromal cells isolated from sternum. If this trait of providing
adequate in vitro niches is common to all bone marrow stromal cells, then I expect to see
an age-related increased in plasma cell survival, as assessed by IgM production. These
sternum-derived stromal cells were generated from the same mice as the femur
experiment and co-cultured with isolated plasma cells from the same sort (Figure 10).
Similar to previous observations, there was a sharp decline in daily IgM production in all
experimental groups between twenty four and ninety six hours (Figure 11). However,
unlike stromal cells derived from femur, young and aged sternum stromal cells both
maintained IgM production, to similar degrees, for the duration of the experiment. It is of
importance to note that when these stromal cells were cultured alone, there was no IgM
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Figure 10: Femur stromal cell age and its role in maintaining plasma cell survival in
vitro. Young (6 week) and old (15 months) stromal cells were cultured with aged (18-24
months) femoral plasma cells for twenty-two days. Supernatants were collected every
three days after the initial set-up (day one). These supernatants were used to assess IgM
production by ELISA. Unpaired t-test (of overall age grouped lines), p=0.113. N=1
experiment.
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Figure 11: Sternum stromal cell age and their role in maintaining plasma cell
survival in vitro. Young (6 week) and old (15 months) sternum stromal cells were
cultured with aged (18-24 months) femoral plasma cells for twenty-five days. Both the
stromal cell and plasma cell sorts were the same as used in Figure 9. Supernatants were
collected every three days after day one. Supernatants were used to assess IgM
production by ELISA. Unpaired t-test p=0.8989 (of overall age grouped lines). N=1
experiment.
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production detected, demonstrating that there is no plasma cell contamination during
stromal cell sorts (data not shown). Although this experiment was only done once, this
preliminary result suggests that cultured stromal cells derived from different bone
marrow sites may act uniquely. This finding, if reproducible, would help researchers
focus on the mechanisms that allow these sites to be different.

The stromal cell data illustrate that (1) aged stromal cells from either marrow
location can maintain IgM production for over twenty days, in this experiment, and (2)
stromal cells from young sternum support plasma cell survival better than those from
young femur (Figures 10 and 11). This led to the last question in regard to the difference
in the microenvironments of both sites. Since aged stromal cells (regardless of location)
are capable of maintaining plasma cells, is there any difference in this process? The
expectation would be that if aged stromal cells had a universal trait in maintaining plasma
cell longevity, then I expect to see similar production of IgM from plasma cells cultured
on stromal cells regardless of site of origin. To test this idea, stromal cells were prepared
from long-term bone marrow cultures generated from the femur or sternum of an
individual mouse. These stromal cells were cultured for three days before plasma cells,
pooled from three mice, were co-cultured with these stromal cells. Regardless of the
origin of the stromal cells in the culture, plasma cells produced roughly the same
concentration of IgM over a twenty four hour period (Figure 12). This suggests that
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while host’s age affects the ability of stromal cells to support plasma cell survival in
vitro, the stromal cells origin does not play a role in this process. Although these coculture experiments hint at mechanisms that may regulate plasma cell survival and
immunoglobulin secretion, it is important to note that the detected amount of IgM in the
supernatants varied greatly (IgM concentrations were 10 times greater in Figure 12
compared to Figure 10). Without repeating these experiments, we are unable to conclude
if this is due to an experimental error, or support the idea that plasma cells are not
uniform in their immunoglobulin production, on a cell to cell basis.
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Figure 12: Aged stromal cells, from femur or sternum, and their capability in
maintaining plasma cell survival in vitro. Stromal cells were isolated from both the
femur and the sternum of an aged (18 months) mouse. 104 stromal cells were cultured
with 5 x 103 femoral plasma cells from aged mice. Supernatants were collected every
three days and IgM concentrations were determined by ELISA. Unpaired t-test
p=0.8733. Each time point is an average of 4 readings and error bars depict SD. N=1
experiment.
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SUMMARY
Research involving plasma cells and their appropriate niches gained interest in the
last decade. Much work has been done to investigate how plasma cells and their niches
work together to elicit protective immunity. However, this research has most often
utilized femoral bone marrow and has not addressed whether differences exist in marrow
sites in regard to either the frequency or maintenance of plasma cells.

My work, however, highlights the importance of observing multiple sites. Since
cortical and membranous bones develop differently, the bone marrow of these two sites
may be influenced to develop differently as well. My work has shown that there is a
trend toward elevated frequencies of plasma cells in the sternum compared to the femur.
My preliminary data demonstrated that sternum plasma cells, as a population, may
produce less IgM. To determine if the plasma cell niches were different in these two
bone marrow sites, I next assessed the ability of the stromal cells to support plasma cells
in vitro. My preliminary work illustrates that unlike femur, sternum does not appear to
have an age-related increase in the ability to support plasma cell survival in vitro.
However, aged stromal cells, regardless of their origin, are equally capable of
maintaining plasma cell survival in culture. These data support the notion that despite the
generally universal mechanisms supporting humoral immunity, there are some
characteristics that are unique to particular host locations (Figure 13).
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Figure 13: Influence of bone marrow origin on plasma cells and their function.
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The percentage of IgM/A/G positive plasma cells were elevated in the sternum
compared to the femur of the same mouse.
In vitro IgM production was only slightly increased from isolated femoral plasma
cells co-cultured on femoral stromal cells, compared to sternum plasma cells.
These two findings suggest that either of these two locations have similar IgM
positive cells, and differences reside in IgA and IgG producing cells, or femoral
plasma cells are capable of secreting more IgM then sternum plasma cells.
Stromal cells from the murine femur have a higher capability of supporting
plasma cell survival in vitro, suggesting that stromal cells may not be uniform in
their production and expression of plasma cell growth factors and surface
molecules.

CHAPTER IV
RESULTS- EXAMINATION OF APRIL AND ITS RECEPTOR TACI IN YOUNG
AND OLD BONE MARROW
Chapter three focused broadly on the bone marrow microenvironment and sought
to determine if there is one common microenvironment, or whether microenvironments
differ depending on their origin. The data suggested that the microenvironments were
similar in maintaining plasma cell survival in vitro, while sternum had an increased
frequency of plasma cells. However, both microenvironments had an overall
accumulation of plasma cells in the aged marrow, demonstrating a shift to mature B cell
phenotypes as the host ages. This chapter will focus on signals provided by the
microenvironment that affect the B cell compartment. In particular, Chapter Four will
assess expression of a signaling molecule, APRIL and one of its receptors, TACI, for
changes with age.
The bone marrow not only provides cellular contact, which is essential for the
survival of many cell types, but also produces various growth factors for the resident cells
(5, 6, 9, 11, 24, 33, 35, 60, 62, 65, 66, 72, 84). These factors provide signals to cells,
driving their maintenance, functionality, and survival in the bone marrow. In particular,
B cells require these signals for their development and production of antibodies. One
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specific signal is provided by the interaction between soluble APRIL and its cognate
receptor, TACI, which is found on all peripheral B cells, including plasma cells (29, 54,
55, 74). APRIL is produced by multiple bone marrow residing cells, including dendritic
cells and activated B cells (54). Once APRIL binds to TACI, this signal activates various
signaling pathways in B cells, by activating signaling molecules and transcription factors
such as NFκB and JNK (54). Activation leads to the expression of genes involved in B
cell development and function.
EXAMINATION OF APRIL TRANSCRIPTS IN THE MURINE BONE
MARROW AND SPLEEN
To determine if a change in the expression of APRIL contributes to the shift to
mature B cells in the aged bone marrow, I assessed APRIL transcripts in various aged
murine femoral and sternum bone marrow samples. By first comparing the APRIL
expression in young and old bone marrow, the question can be asked as to whether
APRIL expression changes with age in these microenvironments. Freshly isolated
femoral or sternum bone marrow was pelleted, at a density of 1 x 106 -10 x 106
cells/pellet. I isolated RNA from the pellets and cDNA was synthesized. Real-Time
PCR analysis compared the expression of APRIL to the constitutively expressed
housekeeping gene HPRT. Since APRIL transcripts have been previously detected in the
spleen, spleen was used as 1) a positive control for our APRIL primers, and 2) a variable,
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to determine if APRIL expression changes in the secondary lymphoid tissue with age
(14). If the shift to mature B cells in the aged bone marrow is due to APRIL expression,
then I expect to detect an elevated expression of APRIL in old bone marrow samples,
when compared to young samples.

As predicted, when femoral bone marrow was assessed for APRIL transcripts,
there was a significant increase in APRIL in the aged femoral bone marrow, compared to
young (Figure 14). This finding suggests that the aged femoral bone marrow is primed to
contribute more APRIL signals than young femoral bone marrow. However, without
assessing APRIL at the protein level, I cannot conclude if aged femoral bone marrow
produces more signaling protein than young.

To determine if sternum also demonstrates this trend in producing more APRIL
transcripts in aged bone marrow, I isolated sternum bone marrow from the same mice as
in the previous experiment (Figure 14). Since sternum also exhibited an increased
frequency of plasma cells in its aged bone marrow microenvironment (Figure 6), I
predicted that the aged sternum bone marrow would contain an increase in APRIL
transcripts compared to young. Similar to what was observed in the femur, there was a
significant increase in APRIL transcript expression in the bone marrow from sternum of
old mice when compared to young (Figure 15). The data suggest that the aged primary
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Figure 14: Expression of APRIL to HPRT in femoral bone marrow. Young (8
weeks) and old (20 months) femoral bone marrow was assessed for APRIL expression by
Real-Time PCR. Results are given as a ratio between APRIL and the housekeeping gene
HPRT. Unpaired t-test, P= 0.0122. N = 3 mice per age group.
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Figure 15: Expression of APRIL to HPRT in sternum bone marrow. Young (8
weeks) and old (20 months) femoral bone marrow was assessed for APRIL expression by
Real-Time PCR. Results are given as a ratio between APRIL and the housekeeping gene
HPRT. Unpaired t-test, P= 0.0056. N = 3 mice per age group.
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lymphoid tissue is more equipped to provide the growth/maintenance APRIL signal than
the primary lymphoid tissue found in young mice. This finding could represent a
mechanism by which the bone marrow facilitates the conversion of the B cell repertoire
from an immature to a mature phenotype.

Thus far, the data suggest that the expression of APRIL transcripts increases in
the bone marrow as the mouse ages. However, a major site of mature B cells and the
developing plasma cells (plasmablasts) is the secondary tissue, in particular the spleen.
Previous research has demonstrated the importance of APRIL in the spleen and how
APRIL’s absence causes the decline of both mature B cells and antibody production (29,
68). Since spleen has been used as a positive control for APRIL expression previously,
we already know that this organ has detectable transcripts in young mouse samples.
However, research has not assessed the basal levels of APRIL transcripts in both young
and old spleens, and whether they remain constant or vary with age. My assumption was
that since there in an increase in plasma cells in the aged host, there would be a consistent
or elevated amount of APRIL transcripts in the old spleen when compared to young
spleen. When assessing APRIL expression by Real-Time PCR, a consistent, significant
elevation in the ratio of APRIL to HPRT in the old (20 months) spleen samples was
observed (Figure 16). This increase supports previous findings implementing the
importance of the secondary lymphoid tissue for the development, survival, and
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maintenance of the mature B cells. It’s possible that this increase in available transcripts
correlates with an increase in APRIL protein, which can facilitate these functions in the
spleen.

The data in Figures 14 through 16 assessed the expression of APRIL in
unimmunized young and old mice. Our earlier findings (see previous chapter) suggest
that, at least in regard to plasma cells, there tended to be a difference in cellular frequency
between femoral and sternum bone marrow. This led me to question whether the
expression of APRIL transcripts also varies between these two bone marrow sites. To
determine if the two bone marrow sites harbor equivalent concentrations of APRIL
transcripts, total bone marrow cells were isolated from the femur and sternum of the same
mouse. These cells were then lysed to obtain cellular RNA and Real-Time PCR was
utilized similar to prior experiments. The prediction was that if the expression of APRIL
affects the overall maintenance of plasma cells in the bone marrow, then an elevated level
of APRIL was expected in the sternum compared to the femur of the same mouse.
Additionally, if the previous propositions were correct, then this prediction would be
evident in both the young and old sternum compared to age-matched femur, due to the
increase in plasma cell frequencies in the sternum, regardless of age (Figure 7).
However, when observing young femoral and sternum bone marrow, the APRIL/HPRT
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Figure 16: Expression of APRIL to HPRT in spleen. Young (8 weeks) and old (20
months) spleen was assessed for APRIL expression by Real-Time PCR. Results are given
as a ratio between APRIL and the housekeeping gene HPRT. Unpaired t-test, P= 0.0356.
N = 3 mice per age group.
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ratio was only slightly elevated in the sternum compared to femur and was not significant
(Figure 17 A). This trend was also apparent in the old femoral and sternum samples;
however, there was more variability in APRIL transcript expression between samples
(Figure 17 B). It remains to be determined if this slight elevation in APRIL transcripts
generates a difference in APRIL protein.

In summary, APRIL is produced by numerous cells in the host, which allows for
APRIL’s function to be displayed in both the primary (bone marrow) and secondary
(spleen) lymphoid tissues. Examination of APRIL transcripts revealed an elevation in
both the primary and secondary lymphoid tissue in aged mice, which were typically
around twenty months of age. To determine if the production of APRIL is similar in both
femoral and sternum bone marrow, I performed Real-Time PCR on bone marrow isolated
from the same mice. These experiments demonstrated that there is similar production of
APRIL in both marrow sites. This section provided additional insight into the expression
of APRIL, as well as illustrating a potential mechanism that contributes to the
accumulation of mature B cells in the older hosts.
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Figure 17: Comparison of APRIL:HPRT ratios in the femoral and sternum bone
marrow. Young (8 weeks) and old (20 months) femoral and sternum bone marrow was
isolated from the same mouse and assessed for APRIL expression by Real-Time PCR.
Results are given as a ratio between APRIL and the housekeeping gene HPRT. Unpaired
t-test P=0.2419 (young) and 0.1109 (old). N=3 experiments per age group. **Important
to note: these experiments were done separately than experiments for figures 14 and 15.
*** See appendix for raw data chart on these results
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EXAMINATION OF TACI EXPRESSION ON VARIOUS B CELL SUBSETS
Cells respond to stimuli based on the engagement of a signaling molecule (ligand)
to its cognate receptor. As previously determined, APRIL is a signaling molecule
produced by the microenvironment. APRIL can bind to TACI, which is located on all
peripheral B cells and plasma cells (56, 68). Upon engagement, a signaling cascade elicit
gene expression important in B cell development and function (7, 13, 54, 56, 68).

Research has determined the cell subsets that express TACI (28, 55, 56, 74, 89).
However, current research has not examined the expression of TACI on B cells from
various aged naïve mice. It is important to determine if elevated expression of APRIL in
aged mice (Figures 14-17) correlated with up-regulation of one of its receptors, TACI.
This helps clarify whether TACI is the receptor preferred in the aged host. To determine
if TACI expression changed on any of the marrow B cell subsets with increased age,
bone marrow cells were flushed from the femoral bones of both young (5-8 weeks) and
old (18-24 months) naïve mice. To discriminate B cell subsets, these cells were stained
with antibodies to B220 (a surface marker to identify the various subsets of B cells),
CD138 (Syndecan-1, a proteoglycan found on the surface of plasma cells) and TACI.
FACS was used to analyze the cells in the bone marrow, based on the expression of these
three markers. Specifically, cell samples were first gated for viable cells, based on their
forward and side scatter (FSC and SSC). Events that fell to the far left corner with
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extremely low FSC and SSC were considered dead cells or cellular debris. In the viable
cell gate, lymphocytes were gated based on low to moderate FSC and low SSC, since a
lymphocyte is typically between seven and ten micrometers in size (Figure 18).
Lymphocytes were selected and segregated based on B220 expression (Figure 19). B220
expression increases as a B lymphocyte matures. B cells that express low levels of B220
are considered a early Pro-B cell, while moderate expression of B220 identifies either a
late Pro-B, Pre-B or immature B cells. Lastly, high expression of surface B220 is used in
concert with additional B cell markers (like surface IgM (BCR) and IgD) to identify more
mature B cell subsets. A B220 negative cell, however, could represent either a non B-cell
or a differentiated plasma cell. To separate these two distinct populations, the
glycoprotein, CD138, was utilized to identify plasma cells (Figure 20). CD138
(Syndecan-1) is a transmembrane heparin sulfate proteoglycan important in cellular
binding and signaling, and has been found to interact with APRIL (38).

Once these subpopulations of B cells were separated in regard to B220
expression, TACI expression was assessed on B cells residing in the murine femoral bone
marrow. To assess TACI expression, I calculated the number of each B cell, per
population, that expressed TACI on their surface per one hundred thousand total
lymphocytes. The prediction is that since APRIL expression increased in the aged bone
marrow, the expression of TACI would also increase on B cells from aged mice. When
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TACI positive B cells were assessed, there was a uniform increase in the number of cells
in all categories found in the aged host (Figure 21). Though a uniform elevation in TACI
positive cells, significance was achieved only in the plasma cells (B220 negative and
CD138 positive) and mature B cells (B220 high).

These findings demonstrate that the mature B cell populations, in the aged host,
are more equipped to respond to the potentially elevated APRIL available in their
microenvironment. This could represent a mechanism by which the microenvironment
provides signals to facilitate the maintenance of these mature cells in vivo. Additionally,
these findings could assist future research in determining if an elevation in APRIL is a
positive regulator to the increased expression of its receptor, TACI or if these two events
are not correlated.

Since the previous results chapter focused on plasma cells and the role the
microenvironment played in their survival, I wanted to conclude my thesis by assessing
the overall frequency of TACI positive plasma cells. Figure 21 depicts the number of B
cells that express TACI on their surface. Though plasma cells accumulate in the aged
marrow, their numbers are still relatively small, especially in comparison to other bone
marrow residing populations. To assess if the plasma cell population, as a whole, has an
up-regulation of TACI on their cell surface, FACS was utilized to gate plasma cells
(B220 negative, CD138 positive lymphocytes). These cells were then gated to determine
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Figure 18: FACS representation of viable cell and lymphocyte gating. These are a
representation of FACS gating of a young (A) and an old (B) murine femoral bone
marrow. First, all viable cells were gated, based on their forward and side scatter. Then,
a lymphocyte gate was drawn, to contain all viable cells that were of small to medium
size, to exclude the larger innate immune cells, like dendritic cells and macrophages.
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Figure 19: FACS representation of B220 expression on lymphocytes. These are a
representation of FACS gating of bone marrow from a young (A) and an old (B) mouse.
Lymphocytes were selected (based on gating from Figure 17), and B220 expression was
divided into four categories (B220 negative, B220 low, B220 moderate low, and B220
high) based on segregation after fluorochrome compensation performed by FACS.
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Figure 20: FACS representation of identified plasma cells from young and old bone
marrow. These are a representation of FACS gating of a young (A) and an old (B)
mouse. B220 negative cells, selected based on expression derived from Figure 19, and
were assessed for expression of CD138 on their surface. The expression of CD138 on
B220 negative cells with appropriate size and granularity (see figure 18), were considered
to be plasma cells. Gating was based on fluorescence minus one compensations and
backgating, to ensure this was indeed a plasma cell population.
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Figure 21: Number of B cells that express TACI on their surface. Based on FACS
analysis, the number of TACI positive B cells were calculated and compared between
young and old mice. N = 9 mice per young group and 6 per old group. P= <0.001 *
(B220-CD138+ and B220 high), P=0.0948 for B220 low and P= 0.1705 for B220
moderate expression.
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the number of TACI expressing cells in this limited sample. TACI positive plasma cell
frequencies were calculated by dividing the number of positive cells by the number of
B220 negative, CD138 positive cells. The prediction is that if APRIL is important for the
maintenance and function of plasma cells in the bone marrow microenvironment, then I
expect to see an increase in the frequency of TACI positive plasma cells in the aged mice.
As predicted, the frequency of B220 negative, CD138 positive cells that were expressing
TACI were significantly elevated in the old mice compared to young (Figure 22).

Similar to the conclusions obtained from figure 21, these results demonstrate that
the frequency of plasma cells expressing TACI is increased as the host ages. However,
the expression of TACI does not appear to be up-regulated per cell, since both the MFI of
TACI is similar on plasma cell from young and old mice (Table 3). Additionally, it
appears that there is a population of plasma cells that are negative for TACI, so we can
conclude that TACI is not the sole signaling receptor required for plasma cell
preservation. Further research is required to identify other signaling pathways critical for
these processes to occur.
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Figure 22: Comparison of TACI positive plasma cells in young and old murine
femoral bone marrow. The bone marrow from young (5-8 week old) and old (18-24
months) was isolated and stained for the cell surface markers B220, CD138, and TACI.
Based on size and granularity, plasma cells were classified based on their lack of B220
and presence of CD138. TACI positive cells were then analyzed, and frequency was
determined. Unpaired t-test was used, and P= 0.0087 * with N= 6 for young and 4 for
old.
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Samples

Average MFI

Standard Deviation

8-10 wk femoral bone
marrow PCs

722

105

18-21 month femoral
bone marrow PCs

733

265

Table 3: Mean Fluorescence Intensity (MFI) of TACI on femoral plasma cells.
FACS analysis determined if TACI was upregulated on individual cells, based on the
MFI. An increase in the MFI suggests that on a single cell, there is an increase in the
number of receptors on the cell surface. However, the MFIs were similar; suggesting that
if a plasma cell is positive for TACI, the expression of TACI is similar, regardless of the
age of the mouse.
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SUMMARY

Overall, this chapter focused on the TNF family ligand, APRIL, and its cognate
receptor, TACI. Since APRIL’s role in B cell survival has been previously established, I
sought to determine if the amount of APRIL transcripts would change as the host ages,
since the B cell compartment is known to change. I concluded that the concentration of
APRIL transcripts is elevated in both the primary (bone marrow) and secondary (spleen)
lymphoid tissue in the aged mouse. However, we do not currently know if this increase
in transcripts correlated with an elevation of available APRIL protein in the
microenvironment. Furthermore, I questioned whether the expression of TACI also
changed with age. Previous research on TACI demonstrated that it facilitates the number
and function of plasma cells in both the spleen and bone marrow. My research suggests
that as the mouse matures, the number of B cells that express TACI increases.
Specifically, the frequency of plasma cells expressing TACI is significantly increased in
the aged murine bone marrow, compared to young (Figures 20 and 21). My research
suggests that a mechanism for B cell survival utilized in the aged host is mediated by
APRIL and TACI. With their uniform elevation in the aged host, it is possible that these
two work in concert to provide adequate survival signals from the environment to the
individual B cells. However, additional work is necessary to determine if these two
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components are required for survival in the aged host, or if they are one of a few
‘redundant’ pathways for this process.

CHAPTER V
DISCUSSION AND FUTURE DIRECTIONS
Understanding the humoral immune system is important in developing adequate
methods to obtain appropriate protective immunity. Long-term plasma cells mediate this
response while residing in the animal’s bone marrow. This microenvironment promotes
plasma cell maintenance and survival. The overarching goal of my thesis was to
determine if the bone marrow is a static or dynamic environment in regard to the bone
marrow-derived plasma and stromal cells and the signals required for humoral immunity.
I addressed this issue in the murine model, using bone marrow location and age as my
variables. Using both ex vivo (FACS, cytodots, and Real-Time PCR) and in vitro (cocultures and ELISA) experiments, I addressed whether the femur and sternum bone
marrows are equivalent (static) in regard to plasma cell frequency, survival, and APRIL
expression. Coinciding with these experiments and additional ones examining the
surface expression of APRIL’s receptor TACI, I addressed the importance of age on the
bone marrow microenvironment and wanted to conclude if age factored in the bone
marrow’s cellular composition, and plasma cell support. Based on the results, age
contributes a prevalent role in the function, composition, and signal molecule availability
in the bone marrow. The implications and future directions will be elaborated upon in the
following sections.
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CHARACTERIZATION OF PLASMA CELLS IN TWO DISTINCT BONE
MARROW SITES

IgM production in femoral and sternum bone marrow. The aged bone
marrow has been used recently as a source for plasma cells in unimmunized mice (62,
63). Though plasma cells are a rare cell population, with a frequency of roughly 0.5- 1%
of the total aged bone marrow, their accumulation in the aged bone marrow allows for
more efficient isolation for in vitro and ex vivo experiments. I first examined the plasma
cell population via total bone marrow culture IgM production and cytodots. IgM is one
of the five immunoglobulin isotypes, and is the primary immunoglobulin found in the
circulation. This is largely due to IgM being the first immunoglobulin produced after an
exposure to an antigen. These traits made IgM an ideal candidate in our naïve mouse
model.

Assessing IgM concentrations in culture supernatants demonstrated an elevation
in sternum bone marrow cells cultured at low cell densities (100,000 cells per well), but
at higher cell densities, the two bone marrow sites had equivalent immunoglobulin
concentrations. Interpretations for this finding include: (1) At lower femoral bone
marrow cell concentrations, there are plasma cell factor(s) that are produced in limited
amounts. For example, a lack of adequate signals, like APRIL, could affect the survival
of these cells, which would affect the secretion of immunoglobulin. (2) At lower cell
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densities, there may be a decrease in plasma cell niches, which facilitate their survival
and function. At a higher density, these limited growth factors and/or niches could reach
equivalent levels in the bone marrow from either location.

Alternatively, since plasma cell frequency was assessed indirectly in the previous
experiment, both the femur and sternum may house equivalent numbers of plasma cells,
despite the difference in immunoglobulin concentrations. ELISPOT experiments on
isolated femoral plasma cells suggested that plasma cells are not uniform in
immunoglobulin secretion since the spots are variable in size (Heather Minges Wols,
unpublished data). Based on these observations, the equal concentrations of IgM found
at 250,000 cells/well does not necessarily have to correlate with equivalent number of
IgM producing plasma cells in the two bone marrow sites. The conclusions from this
experiment are that these two sites appear equivalent in their production of IgM, which
suggests that regardless of the location, the bone marrow microenvironment is uniform in
protecting against an initial encounter with an antigen by producing equivalent amounts
of IgM.

Assessment of plasma cells by cytodots. To specifically characterize the femur
and sternum plasma cells, total bone marrow samples were examined by cytodots.
Plasma cells that secreted either IgM, IgG or IgA were identified based on their
morphology and fluorescence by assessment through microscopy. [Based on the criteria,
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a ‘blinded’ additional investigator determined that an increased frequency of plasma cells
was found in the aged femur and sternum bone marrow, when compared to young.]
Additionally, in data not shown, when experiments were done combining the two
marrows together, there was always an increase in the number of plasma cells in the aged
compared to the young, demonstrating that in aged hosts, the marrow, as a whole,
harbors an accumulation of plasma cells. Thus, the decline in overall humoral immunity
in the elderly may not be due to an insufficient supply of plasma cells, but rather the
amount and/or quality of the immunoglobulin they are producing. Since the
fluorescence appeared similar in intensity between the young and old samples, I speculate
that the decline is in support with previous findings that the quality of antibodies (overall
affinity and diversity) negatively affects the protective humoral response in the elderly
(30, 53, 80).

My results showed that the frequency of IgM, IgG, and IgA positive plasma cells
in the sternum tended to be elevated compared to the femur in individual mice. However,
this finding is not capable of distinguishing which type(s) of immunoglobulin producing
plasma cells are different between the two bone marrow sites. Experiments assessing the
intracellular immunoglobulin, individually, would help determine which plasma cell
subset varied between the sternum and the femur. If the concentrations of IgM detected
in vitro reflect equivalent number of IgM producers in vivo, then the experiments suggest
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the sternum may be the host’s prominant bone marrow site for IgA and IgG plasma cells.
IgA is an antibody important for mucosal immunity. Speculatively, the sternum may be
favored for the location of these cells since the sternum is in close proximity to the
respiratory tract, which is one of the first sites to encounter and recognition of mucosal
antigens. IgG is produced during the secondary infection or exposure to an antigen.
Despite the fact that our mice were not challenged with known antigen, it is possible they
were exposed to non-pathogenic antigens even in barrier colonies. However, without
testing the presence of IgA and IgG positive plasma cells separately, we cannot conclude
which population, out of the two, is truly different between the femur and sternum.
These possibilities could be elucidated with additional FACS, cytodots, and co-culturing
experiments, to assess the immunoglobulin production distinctly, instead of as a whole
population. Moreover, experiments utilizing an infection model could determine if, in
vivo, there is an elevation in the accumulation of these immunoglobulin isotypes in the
sternum. Once each isotype is examined, speculation on in vivo significance can be
determined and further investigated.

ARE THERE INTRINSIC DIFFERENCES IN THE IN VITRO SURVIVAL OF
FEMORAL AND STERNUM PLASMA CELLS?

In vitro survival of plasma cells can be accounted for by the extent of IgM
detected in culture supernatants. The viability of femoral and sternum plasma cells was
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established when these plasma cells were co-cultured on stromal cells isolated from a
single pool of long-term bone marrow cultures (Figure 9). At face value, the femoral
plasma cells appeared to survive better than sternum plasma cells since their supernatants
contained approximately10 ng/ml more IgM per day. Despite the difference in
concentration, both plasma cells demonstrated similar IgM/survival trends. Both the
femoral and sternum plasma cells reached peak survival roughly one week after the initial
co-culturing, and this peak was similar to results obtained by Dr. Heather Minges Wols.
The peak concentration suggests that plasma cells started dying off after about one and a
half weeks, but then the remaining plasma cells were able to maintain their survival
during the second week. Massive cell death, as depicted by a five- fold decline in IgM
from both populations, was observed on day twenty one until day twenty four when the
experiment concluded.

Despite the similar trends, the question remains as to why sternum plasma cells
produce less IgM when compared to femoral plasma cells from the same mouse. It is
possible that sternum plasma cells naturally turn over more rapidly than ones found in the
femur. Future experiments could examine apoptosis of plasma cells in our in vitro coculturing system via ELISA and FACS. The interpretation that the plasma cells
themselves are the cause for the decline in immunoglobulin could be misguided, since it
has yet to be determined if femoral and sternum stromal cells have similar expression of
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adhesion molecules and production of signaling molecules in vivo and in vitro. More
interesting, it is unknown if all plasma cells require the same support in their survival and
maintenance. Hopefully, future work will seek to profile stromal cells, possibly by
microarray or FACS screen to determine if these cells are uniform or distinct in this
capacity. Co-culturing experiments utilizing femoral feeder layers, sternum plasma cells,
and the addition of exogenous in vitro femoral plasma cell survival factors, such as IL-6,
would help elucidate the degree of survival similarity of these two plasma cell
populations.

DOES THE AGE OF THE HOST AFFECT STROMAL CELLS AND THEIR
ABILITY TO SUPPORT PLASMA CELL SURVIVAL IN VITRO?

Since the aged marrow harbors an accumulation of plasma cells, I wanted to ask if
the aged marrow had an enhanced ability to promote in vitro plasma cell survival. I
sorted stromal cells generated from long-term bone marrow cultures from 6 week and 15
month old mice and cultured them with plasma cells from aged femoral bone marrow. I
chose femoral plasma cells for this experiment since they were shown to survive better
under in vitro conditions, when cultured with aged stromal cells, compared to sternum
plasma cells (Figure 9). When femoral plasma cells were cultured on young femurderived stromal cells, survival was low and similar to survival when plasma cells were
cultured alone (Figure 10). In contrast, stromal cells derived from the femoral bone
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marrow of older mice yielded an increase in plasma cell survival, as assessed by the IgM
concentrations detected in their supernatants. When stromal cells from the sternum were
used however, no difference in the level of survival of femoral plasma cells on the two
ages of stromal cells was observed (Figure 11).

These results suggest that age impacts the ability of femoral stromal cells to
support survival in vitro, but does not appear to impact sternum stromal cells. It is
necessary to repeat this particular co-culturing experiment to determine if this finding is
consistant and significant, or if this was a onetime phenomenon. The overall low levels
of IgM detected (approximately 2-5 ng/ml per day) leaves me hesitant, and could be due
to low overall plasma cell survival or possibly human error. In addition, previous data in
the lab utilized young femoral stromal cells in plasma cell co-culturing experiments (62).
In those experiments, stromal cells sorted from long-term bone marrow cultures derived
from young mice, were capable of supporting plasma cells better than media alone. The
same protocols were used, however our young bone marrow was generated from five to
six week old mice while Dr. Minges Wols’ young mice ranged in age from six to twelve
weeks. This difference could represent a window of time that is essential in the
maturation of bone marrow-derived stromal cells and the overall microenvironment. To
determine if that is indeed true, long-term bone marrow cultures could be generated from
six week, eight week, ten week, and twelve week mice and stromal cells from these
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cultures could be used to run parallel co-culture experiments to assess if there are any
differences in survival. Despite the similar protocols, I typically cultured my initial longterm bone marrow cultures a week or two longer than previous experiments. Perhaps this
led to the expansion of one type of stromal cell (reticular or fibroblastic) at the expense of
the other, altering the results. Moreover, despite our endeavors to prevent contamination
of the sort with dead cells, the extended processing could have began necrosis and/or
apoptosis in the cultures that became evident only after the stromal cells were sorted and
placed in the 96-well plate. Regardless of the possibilities, future experiments should
culture the long-term bone marrow cultures for only four weeks, to prevent these
additional variables, which could potentially alter the results.

DOES THE BONE MARROW SITE AFFECT STROMAL CELLS AND THEIR
ABILITY TO SUPPORT PLASMA CELL SURVIVAL?

The previous findings (Figure 9-11) hinted at the idea that the residence of
stromal cells may influence their ability to support plasma cells. In order to directly
address this issue, femoral plasma cells were cultured in the presence of stromal cells
from the aged femur or sternum of an individual mouse. This experiment illustrated that
when femoral plasma cells are cultured on stromal cells from aged hosts, it doesn’t matter
where the bone marrow-derived stromal cells were from (Figure 12). This finding
suggests that while age may factor into the function of stromal cells, the location of their
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residence does not. In this experiment, the survival trends and overall IgM
concentrations were similar to those found in Figure 8; however, the feeder layer from
sternum provided a peak survival later (at day twenty one) than the one from the femur
(at day ten). If this is reproducible, it would suggest that the sternum stromal cells may
provide plasma cell survival factors for a longer duration than the femur.
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SUMMARY AND OVERARCHING HYPOTHESES GENERATED FROM
CHAPTER THREE

This chapter set out to determine if the microenvironments of the femur and the
sternum are similar in ability to support plasma cells. The findings suggest that the bone
marrow may be selective in the plasma cells they support. The sternum may harbor a
higher frequency of IgM/A/G positive plasma cells than the femur. I hypothesize that the
sternum is primed to harbor plasma cells generated to produce antibodies (IgA and IgG)
in response to secondary exposure of antigens. Additionally, it is possible that intrinsic
differences may be present within the plasma cells from these two locations. When the
plasma cells from either site were co-cultured on the same feeder layer (aged femurderived stromal cells), femoral plasma cells had better odds of surviving compared to
sternum-derived plasma cells. This result led me to hypothesize that the interaction
between plasma cells and their niches is unique and based on their appropriate
residence. Last, this section demonstrated that the aged bone marrow-derived stromal
cells increase the survival of in vitro cultures of plasma cells. I hypothesize that stromal
cells from aged mice facilitate the accumulation of plasma cells in the aged host.

Overall, Chapter Three highlights the pitfalls of generalizing the interpretation
from femoral bone marrow to represent all marrow in the animal. Additionally, this
section may help spark the pursuit of mechanisms that regulate and maintain plasma cells
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and their corresponding niches. Understanding these mechanisms and requirements can
help aid the advancement of vaccines that will adequately protect our elderly population.
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DOES THE EXPRESSION OF APRIL CHANGE IN AGED MICE?

The previous chapter strengthened previous findings in our lab demonstrating that
aged microenvironment is different from the ones found in younger mice (41, 61, 62, 82).
To delineate a potential mechanism that may be altered in the aged murine bone marrow,
I examined APRIL and one of its receptors, TACI. This was based on published data
supporting their importance in B cell function and survival (5, 7, 13, 19, 29, 38, 55, 56,
68, 74). Since the B cell subsets mature and differentiate in both the primary and
secondary lymphoid tissues, I assessed both the bone marrow and spleen for changes in
the concentration of APRIL transcripts. Regardless of the tissue examined, APRIL
transcripts were elevated in the aged mouse, as determined by the ratio of APRIL to the
housekeeping gene HPRT (Figures 146-1). These findings demonstrate that the
microenvironment has potential to produce a varied concentration of important growth
factors and signaling molecules, like APRIL.

Additional experiments are required to determine if the elevation in APRIL
transcripts correlates with an increase in the secreted APRIL protein. Multiple
approaches could be utilized to address this question. Quantative analysis, by ELISA,
would verify the concentration of APRIL present in fresh bone marrow or secreted by
total bone marrow and splenic cultures in vitro. In situ hybridization and/or
immunofluorescence staining of bone marrow and splenic sections would help identify
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APRIL producing cells and determine if production is localized to particular cells and/or
locations. These approaches would allow for comparisons between young and old in
regard to ‘who’ is producing APRIL in the various microenvironments. It is feasible to
think that the composition of cells producing APRIL changes with age, in addition to the
amount of APRIL being produced per cell. After the initial survey of the tissue for
APRIL production, clues from those findings can be employed to assess specific cell
types for intracellular APRIL by FACS.

APRIL expression between bone marrow sites. Previous findings suggest that
the sternum bone marrow may harbor more IgM/A/G positive plasma cells, when
compared to the femur (Figure 7). APRIL is important in isotype switching of
immunoglobulins, suggesting that APRIL’s function may be required more in the
sternum than in the femur bone marrow (74). Real-Time PCR concluded that there was a
slight elevation in APRIL transcripts in the sternum compared to the femoral bone
marrow in individual mice (Figure 17). Although not statistically significant, the trend
was similar, in comparison, between the plasma cell frequencies in the two bone marrow
sites (Figure 7). Since isotype switching is a characteristic of secondary immune
reactions, it would be of interest to assess the levels of APRIL in challenged mice. This
would establish if an antigen challenge causes an increase in APRIL in the animal’s bone
marrow. Moreover, challenging mice with differently administrated antigens, such as
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oral antigens, would help delineate the types of encounters (primary and/or secondary)
that facilitate the expansion of available APRIL. Additionally, a challenged setting more
closely mimics the in vivo condition of humans, allowing for more appropriate
correlations to our physiological requirements.

Besides being a general growth factor for B cells, APRIL has been shown to
specifically affect plasma cells. As previously stated, the number of plasma cells
increases as the host gets older. One surface marker on plasma cells is the heparan
sulfate proteoglycan, CD138 (Syndecan-1). Research has concluded that proteoglycans
can bind to available endogenous APRIL in the host and in vitro and this interaction
alone, or in concert with another APRIL receptor generates a signaling cascade in the cell
(38, 74). The question remains as to whether the increases in CD138, in the aged animal,
cause an up-regulation of APRIL, or vice versa. Adoptive transfer experiments could be
used to answer this question. CD138 positive plasma cells, from aged murine bone
marrow, could be transferred into the bone marrow of young mice. This would determine
if the increase in CD138 correlates to an elevation of available APRIL. If the expression
of CD138 leads to the production of APRIL, then young mice that contain the adoptively
transferred plasma cells would have an increase in APRIL transcripts and protein, when
compared to young mice without the transferred cells. Since plasma cells are difficult to
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isolate and transfer, plasmablasts from the spleen of recently challenged aged mice could
be used as well in this experiment.

The previous experiment would determine if the increased expression of CD138
and APRIL in the aged bone marrow correlate with one another. In order to delineate if
the availability of APRIL to bind to CD138 regulates APRIL’s production, old mice
could be injected with a blocking antibody to CD138. By purposely blocking the
receptor, this would conclude if the receptor’s (CD138) availability to bind to its ligand
regulates APRIL expression. If the availability to bind to CD138 affects APRIL
expression, then in the mice injected with the blocking antibody, we expect to see a
decline in APRIL transcripts by Real-Time PCR.

DOES THE EXPRESSION OF TACI ON B CELL SUBSETS CHANGE IN
YOUNG AND OLD MURINE BONE MARROW?

Besides CD138, APRIL can also bind and signal through the TACI receptor on B
cells. Whereas CD138 is restricted to plasma cells, TACI is expressed on multiple B
lineage cells, including immature and mature B cells. FACS analysis was used to
examine the expression of TACI on various B cell populations in the femoral bone
marrow. The bone marrow from femurs was chosen for analysis since the B cell
composition, unlike sternum bone marrow, has been examined in regard to changes with
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age (Figure 3). Gated on lymphocytes, B cell lineage subsets identified based on B220
expression (Figures 18-20). These populations were then examined for relative TACI
expression and the number of TACI positive B cells, per one-hundred thousand
lymphocytes, was determined. The frequency of TACI positive mature B cells (B220
high) and plasma cells (CD138 positive, B220 negative) were significantly increased in
the aged femoral bone marrow compared to the incidence found in the young femoral
microenvironment (Figure 21).

Since the number of plasma cells normally increases in the aged murine bone
marrow, I was not surprised to see a significant increase in TACI positive plasma cells in
the previous experiment. To establish if the frequency of plasma cells expressing TACI
was dependent on the animal’s age, FACS was again used. TACI expression was
assessed solely on the B220 negative, CD138 plasma cell population, and frequency was
determined by dividing the number of TACI positive plasma cells by the total number of
plasma cells found in the host’s bone marrow. This approach revealed that the frequency
of plasma cells expressing TACI was significantly increased in the aged femoral bone
marrow, and that the previous findings were not based solely on the elevation in the
plasma cell subset (Figure 22). Important to note is the fact that although this population
increased, there was not an up-regulation of the expression of this receptor on the cell
surface (Table 3).
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Despite the fact that the frequency of TACI positive plasma cells increased, the
majority of plasma cells were negative for the TACI receptor (Figure 22). If APRIL
facilitates a critical function in the in vivo maintenance and function of plasma cells, then
plasma cells must use additional APRIL receptors to receive this signal. Future research
should look at the expression of BCMA, the final known receptor for APRIL, and
determine if its expression also increases in the aged host. By assessing both TACI and
BCMA on plasma cells would establish if the plasma cell only requires expression and
signaling through one of these receptors for optimal in vivo preservation and function.
FACS would determine surface expression of these receptors, and it would be interesting
to see if there is a population that expresses both receptors. To conclude if the receptors
are truly redundant, or if they facilitate unique properties, plasma cells could be isolated,
based on their receptor expression, and sorted into in vitro stromal cell feeder layers. If
the receptors are interchangeable, then I expect equivalent in vitro survival between
TACI positive and BCMA positive plasma cells.
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SUMMARY AND OVERARCHING HYPOTHESES GENERATED FROM
CHAPTER FOUR

This chapter set out to determine if the expression of the TNF family ligand,
APRIL, and one of its receptors, TACI, changed in the aged femoral and splenic
microenvironments. The data concluded that the aged femoral bone marrow and spleen
generated more APRIL transcripts than the tissue of younger mice. I hypothesize that the
aged bone marrow and spleen generate more APRIL to aide in the function of plasma
cells. In particular, I hypothesize that APRIL’s increase correlates with the increased
requirement for isotype switching. Furthermore, the frequency of TACI positive plasma
cells was elevated in the femur of aged mice. However, the majority of plasma cells were
still negative for TACI. I hypothesize that plasma cells need to express one other APRIL
receptor, in addition to the proteoglycan CD138, to adequately respond to endogenous
APRIL.

Overall, Chapter four assessed the changes in the aged microenvironment, which
is required to provide niches for various B cell subsets. Assessment of APRIL and TACI
demonstrated that their expression increased in the murine primary and secondary
lymphoid tissue. This change could facilitate the change in B cell composition that Dr.
Kara Johnson identified in our lab nearly seven years ago. These findings brought up
additional questions and highlighted potential mechanisms that can be investigated later.

APPENDIX

98

99

BM sample

APRIL copies
(average)

HPRT copies
(average)

APRIL:HPRT

8 week femur

147

8021

0.018

8 week sternum

177

7405

0.024

20 month femur

129

6730

0.019

20 month
sternum

120

6218

0.021

Raw data to correlate with experiments for Figure 17
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